|
1
|
Cannon MJ, Schmid DS and Hyde TB: Review
of cytomegalovirus seroprevalence and demographic characteristics
associated with infection. Rev Med Virol. 20:202–213. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chan G, Nogalski MT, Stevenson EV and
Yurochko AD: Human cytomegalovirus induction of a unique signalsome
during viral entry into monocytes mediates distinct functional
changes: a strategy for viral dissemination. J Leukoc Biol.
92:743–752. 2012. View Article : Google Scholar
|
|
3
|
Crough T and Khanna R: Immunobiology of
human cytomegalovirus: from bench to bedside. Clin Microbiol Rev.
22:76–98. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kenneson A and Cannon MJ: Review and
meta-analysis of the epidemiology of congenital cytomegalovirus
(CMV) infection. Rev Med Virol. 17:253–276. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Santos LF and Carratalà J: Treatment of
cytomegalovirus disease. Enferm Infecc Microbiol Clin. 29:65–69.
2011.
|
|
6
|
Pescovitz MD: Valganciclovir: recent
progress. Am J Transplant. 10:1359–1364. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Powolny AA and Singh SV: Multitargeted
prevention and therapy of cancer by diallyl trisulfide and related
Allium vegetable-derived organosulfur compounds. Cancer
Lett. 269:305–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Durak I, Kavutcu M, Aytac B, Avci A,
Devrim E, Ozbek H and Ozturk S: Effects of garlic extract
consumption on blood lipid and oxidant/antioxidant parameters in
humans with high blood cholesterol. J Nutr Biochem. 15:373–377.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leuschner RGK and Ielsch V: Antimicrobial
effects of garlic, clove and red hot chilli on Listeria
monocytogenes in broth model systems and soft cheese. Int J
Food Sci Nutr. 54:127–133. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu Y, He Z, Shen X, Xu X, Fan J, Wu S and
Zhang D: Cholesterol-lowering effect of allicin on
hypercholesterolemic ICR mice. Oxid Med Cell Longev.
2012:4896902012.PubMed/NCBI
|
|
11
|
Agarwal KC: Therapeutic actions of garlic
constituents. Med Res Rev. 16:111–124. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo NL, Lu DP, Woods GL, Reed E, Zhou GZ,
Zhang LB and Waldman RH: Demonstration of the anti-viral activity
of garlic extract against human cytomegalovirus in vitro. Chin Med
J. 106:93–96. 1993.PubMed/NCBI
|
|
13
|
Liu ZF, Fang F, Dong YS, Li G and Zhen H:
Experimental study on the prevention and treatment of murine
cytomegalovirus hepatitis by using allitridin. Antiviral Res.
61:125–128. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu XL, Wang H, Li YN, Ge HX, Shu SN and
Fang F: Effects of allitridin on acute and chronic mouse
cytomegalovirus infection. Arch Virol. 156:1841–1846. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Murphy E and Shenk T: Human
cytomegalovirus genome. Human Cytomegalovirus: Current Topics in
Microbiology and Immunology. Shenk TE and Stinski MF: Springer; New
York, NY: pp. 1–19. 2008, View Article : Google Scholar
|
|
17
|
White EA, Del Rosario CJ, Sanders RL and
Spector DH: The IE2 60-kilodalton and 40-kilodalton proteins are
dispensable for human cytomegalovirus replication but are required
for efficient delayed early and late gene expression and production
of infectious virus. J Virol. 8125:2573–2583. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gawn JM and Greaves RF: Absence of IE1 p72
protein function during low-multiplicity infection by human
cytomegalovirus results in a broad block to viral delayed-early
gene expression. J Virol. 76:4441–4455. 2002. View Article : Google Scholar
|
|
19
|
Wilkinson GW and Akrigg A: Constitutive
and enhanced expression from the CMV major IE promoter in a
defective adenovirus vector. Nucleic Acids Res. 20:2233–2239. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Greaves RF and Mocarski ES: Defective
growth correlates with reduced accumulation of a viral DNA
replication protein after low-multiplicity infection by a human
cytomegalovirus ie1 mutant. J Virol. 72:366–379. 1998.PubMed/NCBI
|
|
21
|
Arlt H, Lang D, Gebert S and Stamminger T:
Identification of binding sites for the 86-kilodalton IE2 protein
of human cytomegalovirus within an IE2-responsive viral early
promoter. J Virol. 68:4117–4125. 1994.PubMed/NCBI
|
|
22
|
Ahn JH and Hayward GS: The major
immediate-early proteins IE1 and IE2 of human cytomegalovirus
colocalize with and disrupt PML-associated nuclear bodies at very
early times in infected permissive cells. J Virol. 71:4599–4613.
1997.
|
|
23
|
Zhen H, Fang F, Ye DY, et al: Experimental
study on the action of allitridin against human cytomegalovirus in
vitro: inhibitory effects on immediate-early genes. Antiviral Res.
72:68–74. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stinski MF and Petrik DT: Functional roles
of the human cytomegalovirus essential IE86 protein. Curr Top
Microbiol Immunol. 325:133–152. 2008.PubMed/NCBI
|
|
25
|
Aitken C, Barrett-Muir W, Millar C, et al:
Use of molecular assays in diagnosis and monitoring of
cytomegalovirus disease following renal transplantation. J Clin
Microbiol. 37:2804–2807. 1999.
|
|
26
|
De Clercq E and Neyts J: Antiviral agents
acting as DNA or RNA chain terminators. Antiviral Strategies.
Kräusslich HG and Bartenschlager R: Springer; New York: pp. 53–84.
2008
|
